AbCellera Biologics's total assets for Q1 2025 were $1.34B, a decrease of -1.20% from the previous quarter. ABCL total liabilities were $321.23M for the fiscal quarter, a 5.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.